DBSA.F
Banco Santander (Brasil) S.A.
FrankfurtEUREQUITY
Financial Services
DELAYED
Last price
4.70
▼ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
4.70
Prev close
4.70
Day high
4.70
Day low
4.70
Volume
500
Market cap
$35.19B
P/E (TTM)
16.21
52W range
4.22 – 5.95
Day trading desk
Gap from prior close
0.00%
Prior close 4.70
VWAP
4.70
0.00% from price
Relative volume
11.63×
Unusually busy
Session range
—
4.70 – 4.70
Position in range
—
—
ATR (14D)
0.04
0.91% of price
Prior day high
4.70
PDH
Prior day low
4.70
PDL
Bid / ask spread
—
Quote not published
Session volume
500
Avg 43
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.86%
-3.5%
1M
-0.42%
-4.2%
3M
+2.17%
-0.9%
6M
-20.34%
-31.4%
YTD
-7.84%
-20.1%
1Y
+14.08%
-5.9%
3Y
-7.84%
-82.0%
5Y
-18.96%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on DBSA.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
256.32M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 13, 26 | GARRIDO EDUARDO ALVAREZ Officer |
SELL | 410 | $2.34K | Direct |
| Aug 13, 26 | FASOLI FRANCO LUIGI Officer |
SELL | 24.60K | $140.47K | Direct |
| Jun 16, 26 | LEAO MARIO ROBERTO OPICE Chief Executive Officer |
BUY | 276.85K | $1.49M | Indirect |
| Jun 16, 26 | LEAO MARIO ROBERTO OPICE Chief Executive Officer |
SELL | 276.85K | $1.49M | Direct |
| Jun 9, 26 | OHTSUKI VITOR Officer |
SELL | 1.83K | $9.66K | Direct |
| Mar 26, 26 | GARRIDO EDUARDO ALVAREZ Officer |
SELL | 16.50K | $98.17K | Direct |
| Mar 24, 26 | DE ABREU GERMANUELA DE ALMEIDA Officer |
SELL | 55.00K | $325.60K | Direct |
| Mar 24, 26 | ARAUJO ALEXANDRE TEIXEIRA DE Officer |
SELL | 20.16K | $119.73K | Direct |
| Mar 24, 26 | ISHII MICHELE SOARES Officer |
SELL | 12.00K | $71.40K | Direct |
| Mar 19, 26 | KAMBOURAKIS JEAN PAULO Officer |
SELL | 36.72K | $216.29K | Direct |
| Mar 19, 26 | SOARES ALEXANDRE GUIMARAES Officer |
SELL | 35.44K | $209.82K | Direct |
| Mar 18, 26 | KAPPAZ RAFAEL ABUJAMRA Officer |
SELL | 31.29K | $180.20K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARAUJO ALEXANDRE TEIXEIRA DE |
Officer | 18.07K | Sale |
DE ABREU GERMANUELA DE ALMEIDA |
Officer | 45.90K | Sale |
FASOLI FRANCO LUIGI |
Officer | 80.44K | Sale |
GARRIDO EDUARDO ALVAREZ |
Officer | 24.29K | Sale |
ISHII MICHELE SOARES |
Officer | 14 | Sale |
KAMBOURAKIS JEAN PAULO |
Officer | 31.62K | Sale |
KAPPAZ RAFAEL ABUJAMRA |
Officer | 35.05K | Sale |
LEAO MARIO ROBERTO OPICE |
Chief Executive Officer | — | Purchase |
OHTSUKI VITOR |
Officer | 90.89K | Sale |
SOARES ALEXANDRE GUIMARAES |
Officer | 29.29K | Sale |
Fundamentals
Market cap$35.19B
Enterprise value$167.94B
Revenue (TTM)$48.29B
Gross profit$47.47B
EBITDA—
Net income$13.84B
EPS (TTM)$0.29
Free cash flow—
Total cash$171.63B
Total debt$328.95B
Book value / share$11.20
Shares outstanding7.49B
Float1.87B
Short % of float—
Dividend yield6.29%
Beta (5Y)0.18
Valuation & profitability ratios
Trailing P/E16.21
Forward P/E5.34
PEG ratio0.38
Price / sales—
Price / book0.42
EV / revenue3.48
EV / EBITDA—
Gross margin0.00%
Operating margin33.22%
Profit margin28.66%
Return on equity11.15%
Return on assets1.11%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $46.68B | $48.52B | $39.97B | $43.17B | -3.8% |
| Operating revenue | $46.68B | $48.52B | $39.97B | $43.17B | -3.8% |
| Selling, general & admin | $19.37B | $18.87B | $18.07B | $16.78B | +2.6% |
| Pre-tax income | $16.73B | $19.19B | $11.92B | $19.57B | -12.8% |
| Tax provision | $3.76B | $5.78B | $2.42B | $5.24B | -34.8% |
| Net income | $12.77B | $13.37B | $9.45B | $14.29B | -4.5% |
| Net income to common | $6.20B | $6.49B | $4.59B | $6.94B | -4.5% |
| Basic EPS | 1.63 | 1.81 | 1.21 | 1.83 | -9.8% |
| Diluted EPS | 1.63 | 1.81 | 1.21 | 1.83 | -9.8% |
| Basic shares | 3.80B | 7.46B | 3.80B | 3.79B | -49.0% |
| Diluted shares | 3.80B | 7.46B | 3.80B | 3.79B | -49.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $201.98B | $204.88B | $193.99B | $149.64B | -1.4% |
| Property, plant & equipment | $5.05B | $6.02B | $7.09B | $8.19B | -16.2% |
| Goodwill & intangibles | $33.23B | $32.83B | $32.38B | $31.60B | +1.2% |
| Total assets | $1.27T | $1.24T | $1.12T | $985.45B | +2.5% |
| Long-term debt | $28.11B | $23.14B | $19.63B | $126.66B | +21.5% |
| Total debt | $28.11B | $23.14B | $19.63B | $126.66B | +21.5% |
| Total liabilities | $1.14T | $1.12T | $1.00T | $874.77B | +2.2% |
| Retained earnings | $65.37B | $61.45B | $63.92B | $60.44B | +6.4% |
| Shareholder equity | $125.17B | $119.49B | $114.45B | $110.18B | +4.8% |
| Net tangible assets | $91.95B | $86.66B | $82.08B | $78.58B | +6.1% |
| Shares issued | 7.50B | 7.50B | 7.50B | 7.50B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $12.97B | $13.41B | $9.50B | $14.34B | -3.3% |
| Depreciation & amortisation | $2.63B | $2.73B | $2.74B | $2.59B | -3.9% |
| Change in working capital | -$15.55B | -$30.18B | $27.04B | -$52.19B | +48.5% |
| Operating cash flow | $4.99B | -$21.13B | $36.61B | $6.85B | +123.6% |
| Capital expenditure | -$3.66B | -$2.61B | -$3.35B | -$2.86B | -40.1% |
| Investing cash flow | -$3.32B | -$2.02B | -$2.58B | -$2.71B | -64.8% |
| Share buybacks | — | — | — | -$506.28M | — |
| Dividends paid | -$6.50B | -$5.62B | -$5.45B | -$7.39B | -15.6% |
| Financing cash flow | $4.40B | $930.18M | $5.82B | $12.75B | +373.3% |
| Free cash flow | $1.34B | -$23.74B | $33.26B | $3.98B | +105.6% |
| End cash position | $73.27B | $67.20B | $89.42B | $49.57B | +9.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $11.66B | $12.04B | $13.65B | $8.86B | $12.02B | -3.1% |
| Operating revenue | $11.66B | $12.04B | $13.65B | $8.86B | $12.02B | -3.1% |
| Selling, general & admin | $5.02B | $5.13B | $4.40B | $4.96B | $5.03B | -2.3% |
| Pre-tax income | $3.39B | $4.71B | $5.04B | $1.98B | $4.62B | -27.9% |
| Tax provision | $431.27M | $1.43B | $1.10B | -$3.00M | $1.47B | -69.8% |
| Net income | $2.89B | $3.22B | $3.90B | $1.93B | $3.11B | -10.1% |
| Net income to common | $2.89B | $3.22B | -$2.67B | $1.93B | $3.11B | -10.1% |
| Basic EPS | 0.39 | 0.43 | — | 0.26 | 0.42 | -10.1% |
| Diluted EPS | 0.39 | 0.43 | — | 0.26 | 0.42 | -10.1% |
| Basic shares | 7.49B | 7.49B | — | 7.47B | 7.47B | +0.0% |
| Diluted shares | 7.49B | 7.49B | — | 7.47B | 7.47B | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $220.66B | $239.62B | $201.98B | $224.03B | $228.92B | — | -7.9% |
| Property, plant & equipment | $5.74B | $5.04B | $5.05B | $5.71B | $5.67B | — | +13.9% |
| Goodwill & intangibles | $33.16B | $33.14B | $33.23B | $32.87B | $32.81B | — | +0.1% |
| Total assets | $1.29T | $1.29T | $1.27T | $1.24T | $1.25T | — | -0.3% |
| Long-term debt | $31.66B | $29.34B | $28.11B | $24.33B | $23.45B | — | +7.9% |
| Total debt | $31.66B | $29.34B | $28.11B | $24.33B | $23.45B | — | +7.9% |
| Total liabilities | $1.16T | $1.17T | $1.14T | $1.12T | $1.13T | — | -0.4% |
| Retained earnings | $67.35B | $66.46B | $65.37B | — | — | $61.45B | +1.3% |
| Shareholder equity | $127.27B | $126.40B | $125.17B | $122.27B | $120.89B | — | +0.7% |
| Net tangible assets | $94.11B | $93.26B | $91.95B | $89.41B | $88.08B | — | +0.9% |
| Shares issued | 7.50B | 7.50B | 7.50B | 7.50B | 7.50B | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.96B | $3.28B | $3.94B | $1.99B | $3.15B | -9.7% |
| Depreciation & amortisation | $659.76M | $663.28M | $649.39M | $621.32M | $703.34M | -0.5% |
| Change in working capital | $10.03B | $36.27B | -$18.45B | -$16.40B | $24.63B | -72.3% |
| Operating cash flow | $17.73B | $39.60B | -$19.83B | -$11.07B | $32.66B | -55.2% |
| Capital expenditure | -$1.63B | -$665.96M | -$1.51B | -$889.55M | -$499.94M | -144.6% |
| Investing cash flow | -$1.25B | -$506.14M | -$6.20B | $560.23M | -$51.55M | -147.4% |
| Dividends paid | -$1.65B | -$2.17B | $1.13B | -$2.42B | -$1.46B | +24.1% |
| Financing cash flow | -$11.76B | $733.76M | $8.91B | -$5.56B | $2.27B | -1,703.2% |
| Free cash flow | $16.10B | $38.94B | -$21.35B | -$11.96B | $32.16B | -58.7% |
| End cash position | $117.81B | $113.10B | $73.27B | $86.02B | $102.08B | +4.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $21.07B | +1.5% |
| Next quarter | — | — | $21.87B | +3.7% |
| Current year | — | — | $85.11B | +1.9% |
| Next year | — | — | $94.43B | +11.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders13.69%
Held by institutions0.95%
Institutions holding110
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
4.85
-3.17% from price
SMA 20
4.81
-2.27% from price
SMA 50
4.66
+0.89% from price
SMA 100
4.77
-1.56% from price
SMA 200
5.05
-6.97% from price
EMA 12
4.81
-2.20% from price
EMA 26
4.77
-1.47% from price
EMA 50
4.74
-0.79% from price
RSI (14)
46.0
Neutral
MACD (12,26,9)
0.04
Hist -0.03
ATR (14)
0.04
0.91% of price
Realised vol 30D
44.2%
Annualised
Bollinger upper
5.12
20, 2σ
Bollinger lower
4.49
20, 2σ
50 / 200 cross
Death
4.66 vs 5.05
Trend bias
Below 200
-6.97%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.73
Less volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
44.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.4%
Peak to trough
Max drawdown 5Y
-49.9%
Peak to trough
ATR 14
0.04
0.91% of price
Beta (reported)
0.18
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 30, 26 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Jul 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jun 11, 25 | UBS | UPGRADE | Neutral | Buy |
| Nov 25, 24 | JP Morgan | UPGRADE | Neutral | Overweight |
| Oct 16, 23 | Jefferies | INITIATED | — | Hold |
| Jul 27, 23 | Barclays | MAINTAINED | Underweight | Underweight |
| Nov 15, 22 | Barclays | DOWNGRADE | Equal-Weight | Underweight |
| Nov 1, 22 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| Oct 28, 22 | Goldman Sachs | DOWNGRADE | Neutral | Sell |
| Jul 27, 22 | Barclays | MAINTAINED | — | Equal-Weight |
| Jan 14, 22 | Goldman Sachs | UPGRADE | Sell | Neutral |
| Mar 27, 20 | JP Morgan | MAINTAINED | — | Neutral |
Dividends & splits
Forward rate$0.30 / yr
Forward yield6.29%
5-year avg yield6.74%
Payout ratio130.67%
Ex-dividend dateJul 30, 2026
Next pay date—
Last split—
Split date—
Headlines
Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?
Insider Monkey · 6m ago
Dow Jones Futures: Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 9m ago
An $808 monthly payment is reshaping who can afford a new car
TheStreet · 16m ago
UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them.
Motley Fool · 19m ago
Treasury Market Still Functioning, Fed's Kashkari Says
Bloomberg · 20m ago
Former cricket captains appeal to Pakistan over Khan health care
AFP · 21m ago
3 Growth Stocks That Could Skyrocket in the Second Half of 2026
Motley Fool · 21m ago
Nvidia Notifies Customers About AI-Related Price Hikes
Bloomberg · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.